ECSP12012031A - Composición farmacéutica que comprende oligopéptidos - Google Patents
Composición farmacéutica que comprende oligopéptidosInfo
- Publication number
- ECSP12012031A ECSP12012031A ECSP12012031A ECSP12012031A EC SP12012031 A ECSP12012031 A EC SP12012031A EC SP12012031 A ECSP12012031 A EC SP12012031A EC SP12012031 A ECSP12012031 A EC SP12012031A
- Authority
- EC
- Ecuador
- Prior art keywords
- pharmaceutical composition
- oligopeptides
- includes oligopeptides
- lipophilic
- amphiphilic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a una composición farmacéutica de oligopéptidos, con preferencia oligopéptidos cíclicos, en donde dicha composición también comprende uno o varios compuestos lipofílicos y/o anfifílicos, en presencia o ausencia de agua como los ingredientes principales, al uso de los compuestos lipofílicos y/o anfifílicos para preparar composiciones farmacéuticas de dichos oligopéptidos y a métodos de preparación de tal composición farmacéutica.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28531309P | 2009-12-10 | 2009-12-10 | |
US41662810P | 2010-11-23 | 2010-11-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP12012031A true ECSP12012031A (es) | 2012-08-31 |
Family
ID=44145957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP12012031 ECSP12012031A (es) | 2009-12-10 | 2012-07-09 | Composición farmacéutica que comprende oligopéptidos |
Country Status (19)
Country | Link |
---|---|
US (1) | US9433577B2 (es) |
EP (1) | EP2509583B1 (es) |
JP (1) | JP5946770B2 (es) |
KR (1) | KR20120104316A (es) |
CN (1) | CN102652015B (es) |
AU (1) | AU2010330364B2 (es) |
BR (1) | BR112012012862A2 (es) |
CA (1) | CA2783732A1 (es) |
CL (1) | CL2012001310A1 (es) |
EA (1) | EA022700B1 (es) |
EC (1) | ECSP12012031A (es) |
ES (1) | ES2742263T3 (es) |
IL (1) | IL220097A (es) |
MX (1) | MX2012006450A (es) |
NZ (1) | NZ601109A (es) |
PE (1) | PE20121359A1 (es) |
SG (1) | SG181487A1 (es) |
WO (1) | WO2011069629A2 (es) |
ZA (1) | ZA201205103B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8586545B2 (en) | 2009-05-20 | 2013-11-19 | Merck Patent Gmbh | Solid materials of {[(2S, 5R,8S,11S)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acid} and methods for obtaining them |
PL3023788T3 (pl) | 2010-05-14 | 2020-07-27 | The General Hospital Corporation | Kompozycje neoantygenów specyficznych wobec nowotworu do zastosowania w leczeniu nowotworów |
AU2012266803B2 (en) * | 2011-06-09 | 2017-02-02 | Merck Patent Gmbh | Treatment of cancers and metastases with suspensions of cilengitide in carrier |
WO2015077717A1 (en) | 2013-11-25 | 2015-05-28 | The Broad Institute Inc. | Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status |
US11725237B2 (en) | 2013-12-05 | 2023-08-15 | The Broad Institute Inc. | Polymorphic gene typing and somatic change detection using sequencing data |
JP7060324B2 (ja) | 2013-12-20 | 2022-04-26 | ザ・ブロード・インスティテュート・インコーポレイテッド | ネオ抗原ワクチンによる併用療法 |
US10975442B2 (en) | 2014-12-19 | 2021-04-13 | Massachusetts Institute Of Technology | Molecular biomarkers for cancer immunotherapy |
US10993997B2 (en) | 2014-12-19 | 2021-05-04 | The Broad Institute, Inc. | Methods for profiling the t cell repertoire |
TW202346325A (zh) | 2015-05-20 | 2023-12-01 | 美商博德研究所有限公司 | 共有之gata3相關之腫瘤特異性新抗原 |
EP3574116A1 (en) | 2017-01-24 | 2019-12-04 | The Broad Institute, Inc. | Compositions and methods for detecting a mutant variant of a polynucleotide |
SG11202000940XA (en) | 2017-08-24 | 2020-02-27 | Novo Nordisk As | Glp-1 compositions and uses thereof |
TW201930340A (zh) | 2017-12-18 | 2019-08-01 | 美商尼恩醫療公司 | 新抗原及其用途 |
CA3165359A1 (en) | 2020-02-18 | 2021-07-22 | Dorthe Kot Engelund | Glp-1 compositions and uses thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0580778T3 (da) * | 1991-04-19 | 2000-01-31 | Lds Technologies Inc | Konvertible mikroemulsionsformuleringer |
WO1993002665A1 (en) * | 1991-07-26 | 1993-02-18 | Smithkline Beecham Corporation | W/o microemulsions |
DE19534177A1 (de) | 1995-09-15 | 1997-03-20 | Merck Patent Gmbh | Cyclische Adhäsionsinhibitoren |
IL128632A (en) * | 1996-08-22 | 2003-03-12 | Rtp Pharma Corp | Compositions comprising microparticles of water-insoluble substances and method for preparing same |
DE19842415A1 (de) | 1998-09-16 | 2000-03-23 | Merck Patent Gmbh | Pharmazeutische Zubereitung |
UA71608C2 (en) | 1999-03-11 | 2004-12-15 | Merck Patent Gmbh | A method for producing the cyclic pentapeptide |
EP1435910B9 (en) * | 2001-10-19 | 2010-02-03 | Isotechnika Inc. | Novel cyclosporin analog microemulsion preconcentrates |
US6656460B2 (en) * | 2001-11-01 | 2003-12-02 | Yissum Research Development | Method and composition for dry eye treatment |
DE10228049A1 (de) * | 2002-06-24 | 2004-01-15 | Merck Patent Gmbh | Flüssige Zubereitung enthaltend Oligopeptide |
AU2004240640A1 (en) | 2003-05-19 | 2004-12-02 | Baxter International Inc. | Solid particles comprising an anticonvulsant or an immunosuppressive coated with one or more surface modifiers |
EP1750671B1 (en) * | 2004-06-03 | 2008-10-15 | Bracco Research S.A. | Liposomal assembly for therapeutic and/or diagnostic use |
US20100204115A1 (en) * | 2007-09-11 | 2010-08-12 | Dorian Bevec | Use of acetyl- (ala10, 11)-rantes (1-14) and/or calcitonin as anti-angiogenic agents |
RU2555357C2 (ru) * | 2008-04-08 | 2015-07-10 | Мерк Патент Гмбх | Композиции, содержащие циклические пептиды, и способы их применения |
US8586545B2 (en) * | 2009-05-20 | 2013-11-19 | Merck Patent Gmbh | Solid materials of {[(2S, 5R,8S,11S)-5-benzyl-11-(3-guanidino-propyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaaza-cyclopentadec-2-yl]-acid} and methods for obtaining them |
-
2010
- 2010-12-06 CN CN201080055767.4A patent/CN102652015B/zh not_active Expired - Fee Related
- 2010-12-06 EP EP10787035.4A patent/EP2509583B1/en not_active Not-in-force
- 2010-12-06 PE PE2012000796A patent/PE20121359A1/es not_active Application Discontinuation
- 2010-12-06 EA EA201200850A patent/EA022700B1/ru not_active IP Right Cessation
- 2010-12-06 KR KR1020127017966A patent/KR20120104316A/ko not_active Application Discontinuation
- 2010-12-06 MX MX2012006450A patent/MX2012006450A/es not_active Application Discontinuation
- 2010-12-06 WO PCT/EP2010/007396 patent/WO2011069629A2/en active Application Filing
- 2010-12-06 CA CA2783732A patent/CA2783732A1/en not_active Abandoned
- 2010-12-06 BR BR112012012862A patent/BR112012012862A2/pt not_active IP Right Cessation
- 2010-12-06 SG SG2012040754A patent/SG181487A1/en unknown
- 2010-12-06 AU AU2010330364A patent/AU2010330364B2/en not_active Ceased
- 2010-12-06 ES ES10787035T patent/ES2742263T3/es active Active
- 2010-12-06 US US13/515,244 patent/US9433577B2/en active Active
- 2010-12-06 JP JP2012542389A patent/JP5946770B2/ja not_active Expired - Fee Related
- 2010-12-06 NZ NZ601109A patent/NZ601109A/en not_active IP Right Cessation
-
2012
- 2012-05-18 CL CL2012001310A patent/CL2012001310A1/es unknown
- 2012-05-31 IL IL220097A patent/IL220097A/en active IP Right Grant
- 2012-07-09 ZA ZA2012/05103A patent/ZA201205103B/en unknown
- 2012-07-09 EC ECSP12012031 patent/ECSP12012031A/es unknown
Also Published As
Publication number | Publication date |
---|---|
BR112012012862A2 (pt) | 2016-08-16 |
AU2010330364B2 (en) | 2016-05-19 |
WO2011069629A2 (en) | 2011-06-16 |
CN102652015B (zh) | 2016-08-03 |
NZ601109A (en) | 2014-06-27 |
US20120288539A1 (en) | 2012-11-15 |
WO2011069629A3 (en) | 2012-03-15 |
KR20120104316A (ko) | 2012-09-20 |
CN102652015A (zh) | 2012-08-29 |
AU2010330364A1 (en) | 2012-07-26 |
CA2783732A1 (en) | 2011-06-16 |
IL220097A (en) | 2017-03-30 |
US9433577B2 (en) | 2016-09-06 |
EA201200850A1 (ru) | 2013-01-30 |
ZA201205103B (en) | 2013-03-27 |
EA022700B1 (ru) | 2016-02-29 |
MX2012006450A (es) | 2012-06-28 |
ES2742263T3 (es) | 2020-02-13 |
JP2013513556A (ja) | 2013-04-22 |
PE20121359A1 (es) | 2012-10-15 |
CL2012001310A1 (es) | 2012-10-12 |
JP5946770B2 (ja) | 2016-07-06 |
EP2509583B1 (en) | 2019-05-15 |
EP2509583A2 (en) | 2012-10-17 |
SG181487A1 (en) | 2012-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP12012031A (es) | Composición farmacéutica que comprende oligopéptidos | |
GT201400136A (es) | Compuestos y métodos de benzaldehído substituído para su uso en incrementar la oxigenación de los tejidos | |
ECSP12011939A (es) | Compuestos Lipopéptidos y métodos relacionados | |
UY32728A (es) | Composición farmacéutica y procedimiento de tratamiento para la anticoncepción de emergencia | |
CR20120283A (es) | Inhibidor de bromodominio de benzodiazepina | |
ECSP12011935A (es) | Triazolopiridinas | |
GT201200334A (es) | Morfolinopirimidinas y su uso en terapia | |
DOP2014000133A (es) | Triazolopiridinas sustituidas | |
CO6650348A2 (es) | Triazolopiridinas sustituidas | |
DOP2013000244A (es) | Triazolopiridinas | |
CR20120357A (es) | Composición que comprende un pesticida y un alcoxilato de 2-propilheptilamina | |
CO6640301A2 (es) | Compuestos ologo-benzamida y su uso | |
CL2012000508A1 (es) | Composicion para la aplicacion en cultivos agricolas al aire libre o invernaderos que comprende zeolita, y aditivos; uso de la composicion para aumentar el rendimiento de los cultivos agricolas. | |
CL2012003265A1 (es) | Polisacarido de semillas de tamarindo para usarse en el tratamiento de enfermedades infecciosas; composicion farmacéutica y/o dermocosmética antiinflamatoria que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo. | |
CL2013001945A1 (es) | Compuestos derivados de pirazol de fórmulas (ia) o (ib), antagonistas de crth2; composiciones farmaceuticas que los contienen; combinaciones farmaceuticas; su uso en la prevencion y/o el tratamiento de trastornos inflamatorios, infecciosos e inmunorreguladores. | |
BR112013019924A8 (pt) | Composições para cuidado oral | |
CR11755A (es) | Dronedarona para la prevencion de la cardioversion | |
AR075228A1 (es) | Composiciones para el tratamiento del cabello. | |
NZ610950A (en) | Pharmaceutical compositions comprising alisporivir | |
IT1398875B1 (it) | Composizioni contenti l. mucosae per uso medico. | |
TR200909785A1 (tr) | Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar. | |
CL2012001759A1 (es) | Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica. | |
CO6501127A2 (es) | Composiciones farmacéuticas que comprende oligopeptidos | |
TR201109160A2 (tr) | Eplerenon içeren yeni farmasötik kompozisyonlar. | |
PE20140719A1 (es) | Reactivante del color natural del atun y procedimiento para su obtencion |